Elbit Ultrasound Group plans to move its Ausonics division fromSydney, Australia, to the headquarters of Diasonics in Santa Clara,CA. The relocation will result in cost savings due to consolidation,and will also improve cooperation between the divisions
Elbit Ultrasound Group plans to move its Ausonics division from
Sydney, Australia, to the headquarters of Diasonics in Santa Clara,
CA. The relocation will result in cost savings due to consolidation,
and will also improve cooperation between the divisions in developing
new ultrasound technology, according to Ken Marich, director of
marketing communications. Most of Ausonics' key engineers are
expected to make the move, and Ausonics will continue to be a
separate company, maintaining its international distribution network
for products sold under the Ausonics label.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
July 22nd 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.